References
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG,
Enriquez-Sarano M. Burden of valvular heart diseases: a population-based
study.Lancet Lond Engl . 2006;368:1005–11.
2. Ross J, Braunwald E. Aortic stenosis.Circulation .
1968;38:61–7.
3. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu
EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA,
Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ,
Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators.
Transcatheter aortic-valve implantation for aortic stenosis in patients
who cannot undergo surgery.N Engl J Med . 2010;363:1597–607.
4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu
EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S,
Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC,
Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators.
Transcatheter versus surgical aortic-valve replacement in high-risk
patients.N Engl J Med . 2011;364:2187–98.
5. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK,
Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ,
Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR,
Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW,
Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson
WN, Alu MC, Webb JG, PARTNER 2 Investigators. Transcatheter or Surgical
Aortic-Valve Replacement in Intermediate-Risk Patients.N Engl J
Med . 2016;374:1609–20.
6. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia
SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P,
Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY,
Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR, PARTNER 3
Investigators. Transcatheter Aortic-Valve Replacement with a
Balloon-Expandable Valve in Low-Risk Patients.N Engl J Med . 2019.
7. Amat-Santos IJ, Dahou A, Webb J, Dvir D, Dumesnil JG, Allende R,
Ribeiro HB, Urena M, Paradis J-M, DeLarochellière R, Dumont E, Bergeron
S, Thompson CR, Pasian S, Bilodeau S, Leipsic J, Larose E, Pibarot P,
Rodés-Cabau J. Comparison of hemodynamic performance of the
balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter
valve.Am J Cardiol . 2014;114:1075–82.
8. Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S,
Pedrazzini G, Amann FW, Ferrari E, Noble S, Nietlispach F, Maisano F,
Räber L, Roffi M, Grünenfelder J, Jüni P, Huber C, Windecker S,
Wenaweser P. Procedural Results and Clinical Outcomes of Transcatheter
Aortic Valve Implantation in Switzerland: An Observational Cohort Study
of Sapien 3 Versus Sapien XT Transcatheter Heart Valves. Circ
Cardiovasc Interv . 2015;8.
9. Arai T, Lefèvre T, Hovasse T, Morice M-C, Garot P, Benamer H,
Unterseeh T, Hayashida K, Watanabe Y, Bouvier E, Cormier B, Chevalier B.
Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral
transcatheter aortic valve implantation:Difference of valve selection in
the real world.J Cardiol . 2017;69:565–9.
10. Theron A, Pinto J, Grisoli D, Griffiths K, Salaun E, Jaussaud N,
Ravis E, Lambert M, Messous L, Amanatiou C, Cuisset T, Gariboldi V,
Giorgi R, Habib G, Collart F. Patient-prosthesis mismatch in new
generation trans-catheter heart valves: a propensity score
analysis.Eur Heart J Cardiovasc Imaging . 2018;19:225–33.
11. De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S,
Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H. Changes in the
Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3
Transcatheter Aortic Valve Implantation: The Critical Role of Valve
Implantation Height.JACC Cardiovasc Interv . 2016;9:805–13.
12. Tarantini G, Mojoli M, Purita P, Napodano M, D’Onofrio A, Frigo A,
Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S. Unravelling the
(arte)fact of increased pacemaker rate with the Edwards SAPIEN 3
valve.EuroIntervention J Eur Collab Work Group Interv Cardiol Eur
Soc Cardiol . 2015;11:343–50.
13. Gilmanov D, Miceli A, Ferrarini M, Farneti P, Murzi M, Solinas M,
Glauber M. Aortic valve replacement through right anterior
minithoracotomy: can sutureless technology improve clinical outcomes?Ann Thorac Surg . 2014;98:1585–92.
14. Borger MA, Moustafine V, Conradi L, Knosalla C, Richter M, Merk DR,
Doenst T, Hammerschmidt R, Treede H, Dohmen P, Strauch JT. A randomized
multicenter trial of minimally invasive rapid deployment versus
conventional full sternotomy aortic valve replacement.Ann Thorac
Surg . 2015;99:17–25.
15. Dalén M, Biancari F, Rubino AS, Santarpino G, Glaser N, De Praetere
H, Kasama K, Juvonen T, Deste W, Pollari F, Meuris B, Fischlein T,
Mignosa C, Gatti G, Pappalardo A, Svenarud P, Sartipy U. Aortic valve
replacement through full sternotomy with a stented bioprosthesis versus
minimally invasive sternotomy with a sutureless bioprosthesis.Eur
J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg .
2016;49:220–7.
16. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B,
Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J,
Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano
JL, ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the
management of valvular heart disease.Eur Heart J .
2017;38:2739–91.
17. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM,
Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es G-A, Hahn RT,
Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J,
Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated
standardized endpoint definitions for transcatheter aortic valve
implantation: the Valve Academic Research Consortium-2 consensus
document.J Am Coll Cardiol . 2012;60:1438–54.
18. Kocher AA, Laufer G, Haverich A, Shrestha M, Walther T, Misfeld M,
Kempfert J, Gillam L, Schmitz C, Wahlers TC, Wippermann J, Mohr FW, Roth
M, Skwara A, Rahmanian P, Wiedemann D, Borger MA. One-year outcomes of
the Surgical Treatment of Aortic Stenosis With a Next Generation
Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of
rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve
System.J Thorac Cardiovasc Surg . 2013;145:110–5; discussion
115-116.
19. Wahlers TCW, Andreas M, Rahmanian P, Candolfi P, Zemanova B, Giot C,
Ferrari E, Laufer G. Outcomes of a Rapid Deployment Aortic Valve Versus
Its Conventional Counterpart: A Propensity-Matched Analysis.Innov
Phila Pa . 2018;13:177–83.
20. Leveille L, Jaussaud N, Theron A, Riberi A, Collart F. Open-heart
transcatheter aortic valve replacement in complex aortic valve
reoperation: about a case series. Eur Heart J Case Rep .
2018;2:yty064.
21. Durand E, Doutriaux M, Bettinger N, Tron C, Fauvel C, Bauer F,
Dacher J-N, Bouhzam N, Litzler P-Y, Cribier A, Eltchaninoff H.
Incidence, Prognostic Impact, and Predictive Factors of Readmission for
Heart Failure After Transcatheter Aortic Valve Replacement.JACC
Cardiovasc Interv . 2017;10:2426–36.
22. Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D,
Côté M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P,
Dumont E. Incidence, Predictive Factors, and Prognostic Value of
Myocardial Injury Following Uncomplicated Transcatheter Aortic Valve
Implantation.J Am Coll Cardiol . 2011;57:1988–99.
23. Luçon A, Oger E, Bedossa M, Boulmier D, Verhoye JP, Eltchaninoff H,
Iung B, Leguerrier A, Laskar M, Leprince P, Gilard M, Le Breton H.
Prognostic Implications of Pulmonary Hypertension in Patients With
Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve
Implantation: Study From the FRANCE 2 Registry. Circ Cardiovasc
Interv . 2014;7:240–7.
24. Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni
F, Rück A, Barbanti M, Toggweiler S, Thomas M, Khawaja MZ, Hutter A,
Abramowitz Y, Siegel RJ, Cheng W, Webb J, Leon MB, Makkar RR.
Meta-Analysis of the Impact of Mitral Regurgitation on Outcomes After
Transcatheter Aortic Valve Implantation.Am J Cardiol .
2015;115:942–9.
25. Faroux L, Guimaraes L, Wintzer-Wehekind J, Junquera L, Ferreira-Neto
AN, del Val D, Muntané-Carol G, Mohammadi S, Paradis J-M, Rodés-Cabau J.
Coronary Artery Disease and Transcatheter Aortic Valve Replacement.J Am Coll Cardiol . 2019;74:362–72.
26. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal
CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ,
Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT.
Paravalvular regurgitation after transcatheter aortic valve replacement
with the Edwards sapien valve in the PARTNER trial: characterizing
patients and impact on outcomes. Eur Heart J . 2015;36:449–56.
27. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg
L, Neumann F-J, Tarantini G, Zamarano JL, Vahanian A. SOURCE 3 Registry:
Design and 30-Day Results of the European Postapproval Registry of the
Latest Generation of the SAPIEN 3 Transcatheter Heart
Valve.Circulation . 2017;135:1123–32.
28. Herrmann HC, Daneshvar SA, Fonarow GC, Stebbins A, Vemulapalli S,
Desai ND, Malenka DJ, Thourani VH, Rymer J, Kosinski AS.
Prosthesis-Patient Mismatch in Patients Undergoing
Transcatheter Aortic Valve Replacement: From the STS/ACC TVT
Registry.J Am Coll Cardiol . 2018;72:2701–11.
29. Yanagisawa R, Tanaka M, Yashima F, Arai T, Jinzaki M, Shimizu H,
Fukuda K, Watanabe Y, Naganuma T, Higashimori A, Mizutani K, Araki M,
Tada N, Yamanaka F, Otsuka T, Yamamoto M, Hayashida K. Early and Late
Leaflet Thrombosis After Transcatheter Aortic Valve
Replacement.Circ Cardiovasc Interv . 2019;12:e007349.